Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2008-04-08
2008-04-08
Saunders, David A. (Department: 1644)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S391700, C530S395000, C530S402000, C530S403000, C530S866000
Reexamination Certificate
active
07355017
ABSTRACT:
The present invention provides compositions and methods for treating or preventing antibody mediated graft rejection.
REFERENCES:
patent: 6943239 (2005-09-01), Holgersson et al.
patent: WO 98/42750 (1998-10-01), None
Aeed, PA., Geng. J.G., Asa, D., Raycroft, L., Ma, L., and Elhammer, A.P. (1998) Characterization of the 0-linked ollgosaccharide structures on P-selection glycoprotein ligand-I (PSGL-I).Glycoconj. J..15,975.
Aeed, P.A., Geng, J.G., Asa, D., Raycroft, L., Ma, L., and Elhammer, A.P. (2001) Partial characterization of the N-linked oligosaccharide structures on P-selection glycoprotein ligand-a (PSGL-1),Cell, Res., 11, 28.
Alkhunaizi, AM., de Mattos, A.M., Bariy, J.M., Bennett, W.M., and Noiman, D.J. (1999) Renal transplantation across the ABO barrier using A2 kidneys.Transplantation,67, 1319.
Benjamin, R.J. and Antin, J.H. (1999) ABO-incompatible bone marrow transplantation: the transfusion of incompatible plasma may exacerbate regimen-related toxicity.Transfusion, 39, 1273.
Benjamin, RJ., McGurk, S., Ralston, M.S., Churchill, W.H., and Antin, J.H. (1999) ABO incompatibility as an adverse risk factor for survival after allogeneic bone marrow transplantation.Transfusion, 39, 179.
Bensinger. WI. (1981) Plasma exchange and immunoadsorption for removal of antibodies prior to ABO incompatible bone marrow transplant.Artif Organs, 5,254.
Bensinger, W.I., Baker, D.A., Buckner, C.D., Clift, R.A., and Thomas, E.D. (1981) Immunoadsorption for removal of A and B blood-group antibodies.N. Engl. J. Med., 304, 160.
Bensinger, WI., Baker, D.A., Buckner, C.D., Clift, R.A., and Thomas, E.D. (1981b) In vitro and in vivo removal of anti-A erythrocyte antibody by adsorption to a synthetic immunoadsorbent.Transfusion, 21, 335.
Bensinger, W.I., Buckner, CD., Baker, D.A., Clift, R.A., and Thomas, E.D. (1982) Removal of specific antibody in vivo by whole blood immunoadsorption: preliminary results in dogs,),J. Clin. Apheresis., 1,2.
Betteridge, A. and Watkins, W,M. (1985) Variant forms of alphal, 2fucosyltransferase in human submaxillary glands from blood group ABH “secretor” and “non-secretor” individuals.Glycoconj. J., 2,61.
Beyer, T.A., Sadler, J.E. and Hill, R.L. (1980) Purification to homogeneity of H blood group beta-galactoside alpha 1 leads to 2 fucosyltransferase from porcine submaxillary gland.).J. Biol. Chem., 255, 5364.
Carraway, K.L. and Hull, S.R. (1991) Cell surface mucin-type glycoproteins and mucin-like domains.Glycobiology, 1, 131.
Clarke, J.L. and Watkins, W.M. (1999) Expression of human alpha-a-fucosyl-transferase gene homologs in monkey kidney COS cells and modification of potential fucosyltransferase acceptor substrates by an endogenous glycosidase.Glycobiology, 9, 191.
Clausen, H. and Hakomori, S. (1989) ABH and related histo-blood group antigens; immunochemical differences in carrier isotypes and their distribution.Vox. Sang., 56, 1.
Cooper, D.K., Ye, Y., Niekrasz, M., Kehoe, M., Martin, M., Neethling, F.A., Kosanke, S., DeBault, L.E., Worsley, G., Zuhdi, N., and others. (1993) Specific intravenous carbohydrate therapy. A new concept in inhibiting antibody-mediated rejection-experience with ABO-incompatible cardiac allografting in the baboon.Transplantation, 56, 769.
Donald, A. S. (1981) A-active trisaccharides Isolated from A1 and A2 blood-group-specific glycoproteins.Eur. J Biochem., 120, 243.
Eld , A., Zamir, G., Yaron, I., Galun, R., Safadl, R., Schaaps, 1., Berlatzky, V., Shouval, D., and iurim, 0. (1998) Liver transplantation across the ABO barrier: the role pf plasmapheresis.Transplant Proc., 30, 701.
Ernst, L.K., Rajan, V.P., Larson, RD., Ruff, M.M., and Lowe, J,B. (1989) Stable expression of blood H determinants and GDP-L-fucose: betaD-galactoside 2-alpha-L-fucosyltransferase in mouse cells after transfection with human DNA.J. Biol. Chem., 264, 3436.
Fargea,O., Kelil,A.N.,Samuel,D.,Saliba,F.,Anjinaden,i.L., Debat,P., Bismuth,A., Castaing, D., and Bismuth, H. (1995) The use of ABO-incompatible grafts in liver transplantation: a life-saving procedure in highly selected patients.Transplantation, 59, 1124.
Gale, R.P., Feig, S., Ho, Falk, P., Rippee, C., and Sparkes, R. (1977) ABO blood group system and bone marrow transplantation.Blood, 50, 185.
Galili, U. and Matta, K.L. (1996) Inhibition of anti-Gal IgG binding to porcine endothelial cells by synthetic oligosaccharides.Transplantation, 62, 256.
Gibbons, RD., Meltzer, D., and Duan, N. (2000) Waiting for organ transplantation. Institute of Medicine Committee on Organ Transplantation.Science, 287, 237.
Gugenheim, J., Samuel, D., Reynes, M., and Bismuth, H. (1990) Liver transplantation across A130 blood group barriers.Lancet, 336, 519.
Hakomori, S. (1999) Antigen structure and genetic basis of histo-blood groups A, B and 0: their changes associated with human cancer.Biochim. Biophys. Acta, 1473, 247.
Holgersson,J,Breimer, M.E., and Samuelsson, B.E. (1992) Basic biochemistry of cell surface carbohydrates and aspects of the tissue distribution of histo-blood group ABH and related glycosphingolipids.APM'iS Suppl., 27, 18.
Ishikawa, A., Itoh, M., Ushlyama, T., Suzuki, K., and Fujita, K. (1998) Experience of ABO-incompatible living kidney transplantation after double filtration plasinaphersis.Clin. Transplant., 12, 80.
Kelly, Ri., Rouquier, S., Giorgi, D., Lennon, G.G., and Lowe, J.B (1995) Sequence and expression of a candidate for the human Secretor blood group alpha(l, 2)fucosyltransferase gene (FUT2). Homozygosity for an enzyme-inactivating nonsense mutation commonly correlates with the non- secretor phenotype.).Biol. Chem., 270,4640.
Kumazaki, T. and Yoshida, A. (1984) Blochemical evidence that secretor gene, Se, is a structural gene encoding a specific fucosyltransferase.Proc. NatlAcad. Sci. USA, 81,4193.
Kyprianou, P., Betteridge, A. Donald, A.S., and Watkins, W.M. (1990) Purification of the blood group Hgeneassociatedalpha-2-L-fucosyltransferase from human plasma.Glycoconj. J., 573.
Laemmli, U.K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage 14.Nature, 227, 680.
Larsen, R,D., Ernst, L.K., Nair, R.P., and Lowe, J.B. (1990) Molecular cloning, sequence, and expression of a human GDP-L- fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase cDNA that can form the H blood group antigen.Proc. Nail Acad. Sci. USA, 87,6674.
Le Pendu, I., Carton, J.P., Lemieux, R.U., and Oriol, R. (1985) The presence of at least two different H-blood-group-related beta-D-gal alpha-2-L-fuco-syltransferases in human serum and the genetics of blood group H substances.Am. J. Hum. Genet., 37,749.
Liu, J. Qian, Y., and Holgersson, 1. (1997) Removal of xenoreactive human anti-pig antibodies by absorption on recombinant mucin-containing glycoproteins carrying the Gal alphal, 3Gal epitope.Transplantation, 63, 1673-1682.
Liu, Y., Fujitani, N., Koda, V., Soejima, M., and Klmura, H. (1999) Presence of H type 3/4 chains of ABO histo-bbood group system in serious cells of human submandibular gland and regulation of their expression by the secretor gene (FUT2)J. Histochem. Cytochem., 47,889.
Liu, V. H., Fujitani, N., Koda, V., and Kimura, H. (1998) Distribution of H type I and of H type 2 antigens of ABO blood group in different cells of human submandibular gland.).J. Histochem. Cytochem., 46, 69.
Lowe, I. B. (1999) Structures common to different types of glycans. In Varkl, A., Cummings, R., Esko, J., Freeze, H., Hart, G., and Marth, J.. eds., Essentials of Glycobiology. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, 211-252.
Porter, K.A. (1963) Morphological aspects of renal homograft rejection.Br. Med. Bull., 21, 171.
Prieto, P.A., Mukerji, P., Kelder, B., Emey, R., Gonzalez, D., Yun JS., Smith, D.F., Moremen, K.W., Nardelli, C., Pierce, M., and others. (1995) Remodeling of mouse milk glycoconjugates by transgenic expression of a human glycosyltransferase.J. Biol. Chem., 270, 29515.
Rajan, V.P., Larsen, RD., Ajmera, S., Ernst, L.K., and Lowe, J.B. (1989)A cloned human DNA restriction fragment determines expression of a GDP-L-fucose: beta-D-galactoside 2-alpha-L
Holgersson Jan
Lofling Jonas
AbSorber AB
Elrifi Ivor R.
Kozakiewicz Cynthia A.
Mintz Levin Cohn Ferris Glovsky and Popeo P.C.
Saunders David A.
LandOfFree
Blood group antigen fusion polypeptides and methods of use... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Blood group antigen fusion polypeptides and methods of use..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Blood group antigen fusion polypeptides and methods of use... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2763209